TriSalus Life Sciences (TLSI) Inventory (2022 - 2026)

TriSalus Life Sciences has reported Inventory for 5 years, with the latest figure at $3.8 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 9.23% year-over-year to $3.8 million; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (down 9.23% YoY), and the FY2025 full-year result was $3.1 million, down 23.99% from the prior year.
• Inventory for Q1 2026 stood at $3.8 million, up from $3.1 million in the prior quarter.
• The five-year high for Inventory was $4.2 million in Q1 2025, with the low at $1.5 million in Q4 2022.
• Historically, Inventory has averaged $3.2 million across 5 years, with a median of $3.4 million in 2024.
• Annual changes were most pronounced in 2024 — Inventory surged 145.49% — and 2025, when it declined 23.99%.
• TriSalus Life Sciences' Inventory stood at $1.5 million in 2022, then surged by 73.01% to $2.5 million in 2023, then jumped by 59.06% to $4.0 million in 2024, then declined by 23.99% to $3.1 million in 2025, then gained by 22.78% to $3.8 million in 2026.
• The last three Inventory figures came in at $3.8 million (Q1 2026), $3.1 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.